Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)

Key facts

Sponsor

Mansoura University Children Hospital

Principal Investigator

Mohammed A El-Bayoumi, MD, FRCPCH

Head of PICU, Mansoura University Children Hospital

Intervention

IVIG(drug)

Enrollment

41 enrolled

Eligibility

All sexes

Timeline

2007 – 2010

Study locations (1)

• Mansoura University Children Hospital, Al Mansurah, Dakahlia Governorate, Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Functional variant of Guillain-Barré syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT07020819
  An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)
  Annexon, Inc.
• RECRUITINGNANCT06996509
  Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome
  Assiut University
• RECRUITINGNCT06612242
  Early vs. Late Tracheostomy in Patients With Guillain -Barre Syndrome
  Meir Medical Center
• RECRUITINGNANCT06167239
  Ventilator Trigger Sensitivity Adjustment Versus Threshold Inspiratory Muscle Training on Arterial Blood Gases
  Cairo University
• RECRUITINGNCT04829526
  Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome
  University Hospital, Basel, Switzerland

See all trials for Functional variant of Guillain-Barré syndrome →